ARK’s most popular funds include the ARK Innovation ETF (NYSEARCA:ARKK), ARK Next Generation Internet ETF (NYSEARCA:ARKW), and ARK Genomic Revolution ETF (BATS:ARKG). And that means investing heavily in tech, a sector that has been pummeled by interest rates held higher by a Federal Reserve battling runaway inflation. Intellia Therapeutics’ focus on developing gene therapies for cancer, rare diseases, and other genetic disorders promises significant growth and returns for those investors.